In COVID-19 clinical update #104, Daniel Griffin reviews effectiveness of mRNA vaccines among children, number of children affected by disease, accuracy of rapid antigen tests, CDC guidance for prevention strategies, monoclonal antibody effectiveness, predicting progression to severe respiratory failure from pneumonia, risk of long COVID after two vaccine doses, and peripheral neuropathy in long COVID.
Become a patron of TWiV!
Links for this episode
- Vaccine effectiveness 5-11 year olds (medRxiv) 11:29
- Vaccine effectiveness vs ED and UCE 5-12 year olds (MMWR) 13:52
- Children affected by COVID (Lancet) 19:57
- Accuracy of rapid antigen tests (medRxiv) 20:57
- COVID community levels (CDC) 23:21
- Therapeutics guidelines (WHO) 33:33
- Mortality among SOT (Clin Inf Dis) 40:23
- Long COVID after two vaccine doses (medRxiv) 41:09
- Peripheral neuropathy in COVID patients (Neurology) 45:05
- Letters read on TWiV 872 48:17
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees
Send your questions for Dr. Griffin to firstname.lastname@example.org